Companies / Israel
Momenta's Generic Version Of Copaxone To Be Reviewed
July 2008 | Company News AlertThe US FDA has accepted for review Momenta Pharmaceuticals' generic version of Teva Pharmaceutical's Copaxone (glatiramer).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
